Ticker

NEW YORK, April 30, 2026 /PRNewswire/ -- Neuberger High Yield Strategies Fund Inc. (NYSE American: NHS) (the "Fund") has announced a distribution declaration of $0.0905 per share of common stock. The distribution announced today is payable on May 29, 2026, has a record date of May 15, 2026, and has an ex-date of May 15, 2026.

NEW YORK, April 20, 2026 /PRNewswire/ -- Neuberger High Yield Strategies Fund Inc. (NYSE American: NHS) (the "Fund") has announced today the final results of its transferable rights offering (the "Offer"), which expired at 5:00 P.M. Eastern Time on April 15, 2026 (the "Expiration Date").

The Neuberger High Yield Strategies Fund offers a headline 16.66% yield, the highest among closed-end junk bond peers. NHS is not covering its distribution with investment income, as net asset value has declined 10.22% over two years, signaling unsustainable payouts. The fund's portfolio is concentrated in BB and B-rated high-yield bonds, balancing risk and income but sacrificing some yield versus lower-rated debt.

NEW YORK, April 16, 2026 /PRNewswire/ -- Neuberger High Yield Strategies Fund Inc. (NYSE American: NHS) (the "Fund") has announced today the preliminary results of its transferable rights offering (the "Offer"), which commenced on March 23, 2026 and expired on April 15, 2026 (the "Expiration Date"). Pursuant to the Offer, the Fund issued one transferable right (a "Right") for each share of common stock of the Fund…

Novo Nordisk stock surged on Wednesday after a major policy win, which is seen as a turning point for the drugmaker. England's cost-effectiveness watchdog has backed broader use of Wegovy to cut the risk of heart attacks and strokes in overweight or obese adults.